‹ Back
Tirzepatide · How it works
The GIP signal
Tirzepatide binds the GIP receptor as strongly as the body's own GIP. GIP is the gut hormone released from K cells in the upper small bowel after food. In fat tissue, GIP signalling improves blood flow and helps fat cells take up and safely store fat, so less of it spills into the liver and muscle. In the brain, GIP receptors sit in the same appetite centres as GLP-1 receptors and calm the nausea signal, which is part of why the dual signal is easier to carry at high strength.
Sources
Read the original sources
- Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. (Willard · 2020 · Abstract; full methods not assumed · checked 2026-10-13)
- A contemporary rationale for GIP receptor agonism in obesity, Samms 2025, Diabetes (Abstract · checked 2026-10-13)
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. (Coskun · 2018 · Abstract; full methods not assumed · checked 2026-10-13)